Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

French storm over reimbursement reviews:

This article was originally published in Clinica

Executive Summary

The reimbursement review of pharmaceutical products in France is causing considerable controversy. This will worry medical device manufacturers as a similar review is being proposed for medical devices. A transparency commission, the SMR, set up to review reimbursement levels for pharmaceuticals according to the medical usefulness of the product, has recommended that reimbursement levels are not justifiable for some 150 products. Companies have appealed, but during the 56 hearings attended by the president of the pharmacists' professional association, not one company managed to persuade the commission of its case.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT073060

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel